NavaDerm Partners completed a financing with CRG. Through the transaction, NavaDerm will initially access $20 million of debt, with the option to draw a further $10 million at its discretion and upon achieving certain milestones in 2021 and 2022.
EyePoint Pharmaceuticals announced an amendment to its existing debt facility with healthcare investment firm CRG Servicing. The amendment reduces the net product revenue covenant from $80 million to $45 million.
Correvio Pharma amended its existing agreement with CRG Servicing to provide for an increase in capital. Under the terms of the amendment, Correvio is now eligible to receive up to an additional $10 million.
Affiliates of investment firm CRG amended the credit facility for Omeros, a biopharmaceutical company focused on small-molecule and protein therapeutics.
Strongbridge Biopharma entered into a $50 million senior credit facility with CRG. a healthcare-focused investment firm, to retire its existing debt facility and provide additional capital for the company.
Viveve Medical entered into a $30 million senior credit facility with affiliates of CRG to retire its existing credit facility and provide additional capital for the company.
Cardiome Pharma has amended its term loan agreement with CRG-managed funds to provide up to $50 million of available borrowing capacity.